Aug 04, 2024

Hey there!

I’ve got some exciting news to share with you. First off, there’s a virtual event coming up on September 19th that will explore the future of biosimilars. This event will feature industry leaders discussing the value of biosimilars and strategies to advance their adoption, so it’s definitely something you won’t want to miss.

In other news, a recent analysis has found that more and more people without diabetes are using GLP-1 agonist drugs solely for weight loss, which may be contributing to drug shortages. This is an interesting development that’s worth keeping an eye on.

And if you’re a subscriber to STAT+, you’ll get access to some exclusive benefits, including special discounts on STAT events and reports, complimentary access to premium data tools, and subscriber-only newsletters. Plus, there are some upcoming events, like the STAT Summit in October and a session in Washington, DC in September, that subscribers can attend for discounted or free rates.

So, mark your calendars and make sure you don’t miss out on these opportunities to gain valuable insights and stay ahead of the curve in the healthcare industry.

Take care,

Summy

Stay Well!